HIV/AIDS medical research Pedriactic Health
FDA Approves Drug to Treat HIV Infection in Newborns
By Michael Gwarisa The U.S. Food and Drug Administration (FDA) has approved a new formulation of the HIV medicine dolutegravir for use in newborns from birth through four weeks of age, expanding treatment options for one of the most vulnerable groups at risk of HIV infection. The approval covers Tivicay PD tablets for oral suspension
Read More
Breaking News Features Pedriactic Health
A 75-Seater Bus of Newborns Crashes Every 12 Hours in Zimbabwe. We Must Hit the Brakes
By Michael Gwarisa Every twelve hours in Zimbabwe, an unimaginable tragedy unfolds. A fully loaded 75-seater bus carrying newborn babies crashes, leaving no survivors. The nation would demand answers, declare emergencies, and mobilize every resource to prevent another disaster. Yet this exact horror plays out in silence daily. According to the 2023-24 Zimbabwe Demographic and Health
Read More